Lack of Antinuclear Antibodies in Convalescent Coronavirus Disease 2019 Patients With Persistent Symptoms

doi:10.1093/cid/ciab890

Comment

. 2022 Jun 10;74(11):2083-2084.

doi: 10.1093/cid/ciab890.

Lack of Antinuclear Antibodies in Convalescent Coronavirus Disease 2019 Patients With Persistent Symptoms

Michael J Peluso¹, Isaac J Thomas², Sadie E Munter², Steven G Deeks¹, Timothy J Henrich²

Affiliations

¹ Division of HIV, Infectious Diseases, and Global Medicine, University of California San Francisco, San Francisco, California, USA.
² Division of Experimental Medicine, University of California, San Francisco, California, USA.

PMID: 34617982
PMCID: PMC9187313
DOI: 10.1093/cid/ciab890

Comment

Lack of Antinuclear Antibodies in Convalescent Coronavirus Disease 2019 Patients With Persistent Symptoms

Michael J Peluso et al. Clin Infect Dis. 2022.

. 2022 Jun 10;74(11):2083-2084.

doi: 10.1093/cid/ciab890.

Authors

Michael J Peluso¹, Isaac J Thomas², Sadie E Munter², Steven G Deeks¹, Timothy J Henrich²

Affiliations

¹ Division of HIV, Infectious Diseases, and Global Medicine, University of California San Francisco, San Francisco, California, USA.
² Division of Experimental Medicine, University of California, San Francisco, California, USA.

PMID: 34617982
PMCID: PMC9187313
DOI: 10.1093/cid/ciab890

No abstract available

PubMed Disclaimer

Comment in

Reply to Peluso et al.
Seeßle J, Naujokat C, Oberacker P, Peters WH, Waterboer T, Müller B, Merle U. Seeßle J, et al. Clin Infect Dis. 2022 Jun 10;74(11):2084-2085. doi: 10.1093/cid/ciab892. Clin Infect Dis. 2022. PMID: 34617996 No abstract available.

Comment on

Persistent Symptoms in Adult Patients 1 Year After Coronavirus Disease 2019 (COVID-19): A Prospective Cohort Study.
Seeßle J, Waterboer T, Hippchen T, Simon J, Kirchner M, Lim A, Müller B, Merle U. Seeßle J, et al. Clin Infect Dis. 2022 Apr 9;74(7):1191-1198. doi: 10.1093/cid/ciab611. Clin Infect Dis. 2022. PMID: 34223884 Free PMC article.

Cited by

Characterizing and Predicting Post-Acute Sequelae of SARS CoV-2 Infection (PASC) in a Large Academic Medical Center in the US.
Fritsche LG, Jin W, Admon AJ, Mukherjee B. Fritsche LG, et al. J Clin Med. 2023 Feb 7;12(4):1328. doi: 10.3390/jcm12041328. J Clin Med. 2023. PMID: 36835863 Free PMC article.
Immune mechanisms underlying COVID-19 pathology and post-acute sequelae of SARS-CoV-2 infection (PASC).
Mohandas S, Jagannathan P, Henrich TJ, Sherif ZA, Bime C, Quinlan E, Portman MA, Gennaro M, Rehman J; RECOVER Mechanistic Pathways Task Force. Mohandas S, et al. Elife. 2023 May 26;12:e86014. doi: 10.7554/eLife.86014. Elife. 2023. PMID: 37233729 Free PMC article. Review.
Post COVID-19 joint pain: Preliminary report of the relationship with antinuclear antibodies and inflammation.
Tamariz L, Bast E, Abad M, Klimas N, Caralis P, Palacio A. Tamariz L, et al. J Med Virol. 2022 Aug;94(8):3479-3481. doi: 10.1002/jmv.27753. Epub 2022 Apr 9. J Med Virol. 2022. PMID: 35355291 Free PMC article. No abstract available.
Long COVID endotheliopathy: hypothesized mechanisms and potential therapeutic approaches.
Ahamed J, Laurence J. Ahamed J, et al. J Clin Invest. 2022 Aug 1;132(15):e161167. doi: 10.1172/JCI161167. J Clin Invest. 2022. PMID: 35912863 Free PMC article. Review.
Plasma Markers of Neurologic Injury and Inflammation in People With Self-Reported Neurologic Postacute Sequelae of SARS-CoV-2 Infection.
Peluso MJ, Sans HM, Forman CA, Nylander AN, Ho HE, Lu S, Goldberg SA, Hoh R, Tai V, Munter SE, Chenna A, Yee BC, Winslow JW, Petropoulos CJ, Martin JN, Kelly JD, Durstenfeld MS, Hsue PY, Hunt PW, Greene M, Chow FC, Hellmuth J, Henrich TJ, Glidden DV, Deeks SG. Peluso MJ, et al. Neurol Neuroimmunol Neuroinflamm. 2022 Jun 14;9(5):e200003. doi: 10.1212/NXI.0000000000200003. Print 2022 Sep. Neurol Neuroimmunol Neuroinflamm. 2022. PMID: 35701186 Free PMC article.

See all "Cited by" articles

References

1. Seeßle J, Waterboer T, Hippchen T, et al. . Persistent symptoms in adult patients one year after COVID-19: a prospective cohort study. Clin Infect Dis 2021. - PMC - PubMed
1. Wallukat G, Hohberger B, Wenzel K, et al. . Functional autoantibodies against G-protein coupled receptors in patients with persistent long-COVID-19 symptoms. J Transl Autoimmun 2021; 4:100100. - PMC - PubMed
1. Sacchi MC, Tamiazzo S, Stobbione P, et al. . SARS-CoV-2 infection as a trigger of autoimmune response. Clin Transl Sci 2021; 14:898-907. - PMC - PubMed
1. Guilmot A, Maldonado Slootjes S, Sellimi A, et al. . Immune-mediated neurological syndromes in SARS-CoV-2-infected patients. J Neurol 2021; 268:751-7. - PMC - PubMed
1. Peluso MJ, Kelly JD, Lu S, et al. . Rapid implementation of a cohort for the study of post-acute sequelae of SARS-CoV-2 infection/COVID-19. medRxiv 2021. doi:10.1101/2021.03.11.21252311. - DOI

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

Grants and funding

R01 AI141003/AI/NIAID NIH HHS/United States

LinkOut - more resources

Full Text Sources
Medical
- MedlinePlus Health Information

[1] Seeßle J, Waterboer T, Hippchen T, et al. . Persistent symptoms in adult patients one year after COVID-19: a prospective cohort study. Clin Infect Dis 2021. - PMC - PubMed

[2] Seeßle J, Waterboer T, Hippchen T, et al. . Persistent symptoms in adult patients one year after COVID-19: a prospective cohort study. Clin Infect Dis 2021. - PMC - PubMed

[3] Wallukat G, Hohberger B, Wenzel K, et al. . Functional autoantibodies against G-protein coupled receptors in patients with persistent long-COVID-19 symptoms. J Transl Autoimmun 2021; 4:100100. - PMC - PubMed

[4] Wallukat G, Hohberger B, Wenzel K, et al. . Functional autoantibodies against G-protein coupled receptors in patients with persistent long-COVID-19 symptoms. J Transl Autoimmun 2021; 4:100100. - PMC - PubMed

[5] Sacchi MC, Tamiazzo S, Stobbione P, et al. . SARS-CoV-2 infection as a trigger of autoimmune response. Clin Transl Sci 2021; 14:898-907. - PMC - PubMed

[6] Sacchi MC, Tamiazzo S, Stobbione P, et al. . SARS-CoV-2 infection as a trigger of autoimmune response. Clin Transl Sci 2021; 14:898-907. - PMC - PubMed

[7] Guilmot A, Maldonado Slootjes S, Sellimi A, et al. . Immune-mediated neurological syndromes in SARS-CoV-2-infected patients. J Neurol 2021; 268:751-7. - PMC - PubMed

[8] Guilmot A, Maldonado Slootjes S, Sellimi A, et al. . Immune-mediated neurological syndromes in SARS-CoV-2-infected patients. J Neurol 2021; 268:751-7. - PMC - PubMed

[9] Peluso MJ, Kelly JD, Lu S, et al. . Rapid implementation of a cohort for the study of post-acute sequelae of SARS-CoV-2 infection/COVID-19. medRxiv 2021. doi:10.1101/2021.03.11.21252311. - DOI

[10] Peluso MJ, Kelly JD, Lu S, et al. . Rapid implementation of a cohort for the study of post-acute sequelae of SARS-CoV-2 infection/COVID-19. medRxiv 2021. doi:10.1101/2021.03.11.21252311. - DOI

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Lack of Antinuclear Antibodies in Convalescent Coronavirus Disease 2019 Patients With Persistent Symptoms

Affiliations

Lack of Antinuclear Antibodies in Convalescent Coronavirus Disease 2019 Patients With Persistent Symptoms

Authors

Affiliations

Comment in

Comment on

Similar articles

Cited by

References

Publication types

MeSH terms

Substances

Grants and funding

LinkOut - more resources

Full Text Sources

Medical